Event Abstract Back to Event Partial Seizures Jorge J. Asconapé1* 1 Loyola University Health System, Department of Neurology, United States Learning objectives: Describe the most frequent clinical manifestations of partial seizures related to the anatomic region of origin Understand the modern drug selection process for the medical treatment of partial seizures Identify the syndrome of Mesial Temporal Lobe Epilepsy secondary to hippocampal sclerosis, and the role of temporal lobectomy. Identify the role of surgery and neuromodulation in the management of patients with pharmaco-resistant partial epilepsy. The temporal lobes are the most frequent source of partial seizures in clinical practice. Approximately 70% of complex partial seizures originate in the temporal lobes. Temporal lobe epilepsy is divided in two types: mesial temporal lobe epilepsy (MTLE) and lateral or neocortical temporal lobe epilepsy (LTLE). Distinguishing these two types is difficult clinically, since the seizure semiology is very similar, but becomes an important issue when surgery is considered. The frontal lobes are the second most common location of seizure foci; they are also the second most common location where resective surgery is performed. From an anatomo-clinical perspective, seven distinct areas have been delineated in the frontal lobes epilepsies. Occipital lobe seizures are more rare, accounting for < 10% of all the epilepsies. The first line of therapy of partial seizure is almost always medical. Practically every antiepileptic drug currently available can be effective in controlling partial seizures, making the process of drug selection relatively easy. The choice of a drug is mostly based on its tolerability profile and its drug interaction potential. If seizures remain poorly controlled after adequate trials of 2 to 4 antiepileptic drugs, as monotherapy or in different combinations, patients should be evaluated for possible epilepsy surgery. Anterior temporal lobectomy or selective amygdalo-hippocampectomy is the therapy of choice as soon as refractoriness to medical therapy has been established. Neuromodulation has been utilized in the treatment of epilepsy for several decades, but has become more widely used in recent years. Vagus nerve stimulation remains an effective and safe palliative therapy for partial seizures. Deep brain stimulation of the anterior nucleus of the thalamus has recently been proven effective in a well-controlled study, and is currently being reviewed by the FDA. Responsive neurostimulation is another promising technique currently under clinical investigation. Conference: Paroxysmal Neurology Symposium, Chicago, United States, 7 Apr - 7 Apr, 2010. Presentation Type: Oral Presentation Topic: Abstracts Citation: Asconapé JJ (2010). Partial Seizures. Front. Neurol. Conference Abstract: Paroxysmal Neurology Symposium. doi: 10.3389/conf.fneur.2010.07.00007 Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters. The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated. Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed. For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions. Received: 07 Apr 2010; Published Online: 07 Apr 2010. * Correspondence: Jorge J Asconapé, Loyola University Health System, Department of Neurology, Maywood, IL, United States, jasconape@lumc.edu Login Required This action requires you to be registered with Frontiers and logged in. To register or login click here. Abstract Info Abstract The Authors in Frontiers Jorge J Asconapé Google Jorge J Asconapé Google Scholar Jorge J Asconapé PubMed Jorge J Asconapé Related Article in Frontiers Google Scholar PubMed Abstract Close Back to top Javascript is disabled. Please enable Javascript in your browser settings in order to see all the content on this page.